Simpson Thacher represented CVC Capital Partners ("CVC") in connection with the formation and raising of CVC Capital Partners VII ("Fund VII"), CVC’s latest flagship fund for private equity investments in Europe and North America.

The fund closed with a hard cap of €15.5 billion. Together with the commitments of CVC and its employees, Fund VII will have over €16 billion of equity capital available to invest. It is the largest European fundraising on record.

Beijing – Paul Hastings LLP announced today that it represented Green Tea Restaurant (“the Company”) and its founders in receiving investment from Partners Group, a global private markets investment manager. Green Tea Restaurant is a leading Chinese casual dining restaurant chain.

Herbert Smith Freehills has advised Malaysia's Axiata Group Bhd on the sale of a 10% stake in its Cambodian mobile subsidiary to Japan's Mitsui & Co., Ltd.

Axiata will retain an 82.5% stake in Smart Axiata Co Ltd, Cambodia's leading mobile service provider with over 8 million customers.

Allen & Overy LLP has advised Landesbank Hessen-Thüringen Girozentrale in connection with the investment of UK private equity firm 3i in Lampenwelt, Europe's largest online specialist in the lighting space. 3i will invest alongside management and one of the current owners of the business, Walter Neumüller.

Clifford Chance has advised Swiss Re in the framework of its investment in Manzi Finances SA, majority shareholder of NSIA Participations, insurance and banking group with operations in 12 Sub-Saharan African countries.

VISCHER advises Inthera Bioscience AG, a Zurich based biopharmaceutical company, developing first-in-class targeted small molecule therapies for solid tumors.

The CHF 10.5 m (EUR 9.6 m) series A financing round was led by Merck Ventures, with equal contribution from Aglaia BioMedical Ventures and Novo Seeds and the participation of a private investor.

Summa Equity has invested in Ivbar Institute AB ("Ivbar"). Ivbar is a Swedish digital health company that has developed a big data analytics technology that enables improved management of healthcare through a focus on patient value. The platform improves transparency and provides unique levels of insights into both patient outcomes and resource allocation.

Taylor Wessing has advised Rutland Partners on its investment in Omar Group, the UK’s leading designer and manufacturer of park homes and luxury lodges.

Omar represents an exciting scale opportunity for Rutland to support Dean Westmoreland and an experienced management team to further expand and build on the current operational and expansion plans for the business.

Simmons & Simmons has, together with Rex Bionics company secretary, Keith Robinson, of Sherrards Solicitors, advised Rex Bionics Plc (the “Company”), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, on a major restructuring of its group. This has permitted an initial investment of AUD7.5m (approximately £4.4m) and a new development agreement.

Walder Wyss advises Evolute Group AG, Zug, on its Series A financing round. The financing round amounts to CHF 6 mio. and was subscribed by investors from the financial and start-up sector.